Global Subcutaneous Immunoglobulins Market Research Report 2022

Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).
Due to the COVID-19 pandemic, the global Subcutaneous Immunoglobulins market size is estimated to be worth US$ 4371.4 million in 2021 and is forecast to a readjusted size of US$ 9807.2 million by 2028 with a CAGR of 12.1% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Subcutaneous Immunoglobulins market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Subcutaneous Immunoglobulins landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
In United States, Subcutaneous Immunoglobulins key players include Shire (Baxalta), Grifols, etc. Global top two manufacturers hold a share over 90%.
South is the largest market, with a share about 35%, followed by West, and Northeast, both have a share about 45 percent.
In terms of product, 10% Purity is the largest segment, with a share over 75%. And in terms of application, the largest application is Primary Immunodeficiency, followed by Secondary Immunodeficiency, etc.
This report focuses on Subcutaneous Immunoglobulins volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Subcutaneous Immunoglobulins market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Australia, etc.
Global Subcutaneous Immunoglobulins Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Purity and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Purity
0.1
0.2

Segment by Application
Primary Immunodeficiency
Secondary Immunodeficiency
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Shire (Baxalta)
Grifols
CSL